Added value of diffusion-weighted imaging in the MRI assessment of perilesional tumor recurrence after chemoembolization of hepatocellular carcinomas

Journal of Magnetic Resonance Imaging

Volumn 30, Issue 1, 2009, Pages 153-160

  Yu, Jeong Sik ^a   Joo, Hee Kim ^a   Chung, Jae Joon ^a   Ki, Whang Kim ^a  

^a Yonsei University College of Medicine   (South Korea)

Author keywords

Chemoembolization; Diffusion weighted imaging; Hepatocellular carcinoma; Liver; MRI

Indexed keywords

GADOLINIUM PENTETATE MEGLUMINE;

ADULT; AGED; ARTICLE; CANCER PATIENT; CHEMOEMBOLIZATION; CLINICAL ARTICLE; CONTRAST ENHANCEMENT; DIAGNOSTIC ACCURACY; DIFFUSION WEIGHTED IMAGING; FEMALE; HUMAN; IMAGE ANALYSIS; LIVER CELL CARCINOMA; MALE; OUTCOME ASSESSMENT; PRIORITY JOURNAL; RECEIVER OPERATING CHARACTERISTIC; SENSITIVITY AND SPECIFICITY; TUMOR RECURRENCE;

ADULT; AGED; AREA UNDER CURVE; CARCINOMA, HEPATOCELLULAR; CHEMOEMBOLIZATION, THERAPEUTIC; CONTRAST MEDIA; DIFFUSION MAGNETIC RESONANCE IMAGING; FEMALE; GADOLINIUM DTPA; HUMANS; IMAGE ENHANCEMENT; LIVER; LIVER NEOPLASMS; MALE; MIDDLE AGED; NEOPLASM RECURRENCE, LOCAL; OBSERVER VARIATION; PREDICTIVE VALUE OF TESTS; REPRODUCIBILITY OF RESULTS; SENSITIVITY AND SPECIFICITY;

EID: 67650077120     PISSN: 10531807     EISSN: 15222586     Source Type: Journal    
DOI: 10.1002/jmri.21818     Document Type: Article

References (30)

1. Nakamura H, Tanaka T, Hori S, et al. Transcatheter embolization of hepatocellular carcinoma; assessment of efficacy of resection following embolization. Radiology 1983;147:401-405. (Pubitemid 13133211)
2. Hsu HC, Wei TC, Tsang YM, et al. Histologic assessment of resected hepatocellular carcinoma after transcatheter hepatic arterial embolization. Cancer 1986;57:1184-1191. (Pubitemid 16166230)
3. Lee JK, Chung YH, Song BC, et al. Recurrences of hepatcellular carcinoma following initial remission by transcatheter arterial chemoembolization. J Gastroenterol Hepatol 2002;17:52-58. (Pubitemid 34304387)
4. Murakami T, Nakamura H, Hori S, et al. Detection of viable tumor cells in hepatocellular carcinoma following transcatheter arterial chemoembolization with iodized oil. Acta Radiol 1993;34:399-403.
5. Jang KM, Choi D, Lim HK, et al. Depiction of viable tumor in hepatocellular carcinoma treated with transarterial chemoembolization: multiphasic helical CT with review of previous serial CT images. Korean J Radiol 2005;6:153-160. (Pubitemid 41296874)
6. Imaeda T, Yamawaki Y, Seki M, et al. Lipiodol retention and massive necrosis after Lipiodol-chemoembolization of hepatocellular carcinoma; correlation between computed tomography and histopathology. Cardiovasc Intervent Radiol 1993;16:209-213. (Pubitemid 23204501)
7. Tanaka K, Nakamura S, Numata K, et al. Hepatocellular carcinoma: treatment with percutaneous ethanol injection and transcatheter arterial embolization. Radiology 1992;185:457-460.
8. Kim DE, Kim PN, Lee HJ, et al. Vasculature in hepatocellular carcinoma after transcatheter arterial chemoembolization: comparison of power and color Doppler sonography. J Ultrasound Med 1998;17:9-15. (Pubitemid 28023918)
9. Murakami T, Nakamura H, Tsuda K, et al. Treatment of hepatocellular carcinoma by chemoembolization: evaluation with 3DFT MR imaging. AJR Am J Roentgenol 1993;160:295-299. (Pubitemid 23059216)
10. Ito K, Honjo K, Fujita T, et al. Therapeutic efficacy of transcatheter arterial chemoembolization for hepatocellular carcinoma; MRI and pathology. J Comput Assist Tomogr 1995;19:198-203.
11. Kubota K, Hisa N, Nishikawa T, et al. Evaluation of hepatocellular carcinoma after treatment with transcatheter arterial chemoembolization: comparison of Lipiodol-CT, power Doppler sonography, and dynamic MRI. Abdom Imaging 2001;26:184-190. (Pubitemid 32187124)
12. Chen CY, Li CW, Kuo YT, et al. Early response of hepatocellular carcinoma to transcatheter arterial chemoembolization: choline levels and MR diffusion constants-initial experience. Radiology 2006;239:448-456.
13. Deng J, Rhee TK, Sato KT, et al. In vivo diffusion-weighted imaging of liver tumor necrosis in the VX2 rabbit model at 1.5 Tesla. Invest Radiol 2006;41:410-414.
14. Kamel IR, Bluemke DA, Eng J, et al. The role of functional MR imaging in the assessment of tumor response after chemoembolization in patients with hepatocellular carcinoma. J Vasc Interv Radiol 2006;17:505-512. (Pubitemid 44318722)
15. Deng J, Miller FH, Rhee TK, et al. Diffusion-weighted MR imaging for determination of hepatocellular carcinoma response to Yttrium-90 radioembolization. J Vasc Interv Radiol 2006;17:1195-1200. (Pubitemid 44318703)
16. Goshima S, Kanematsu M, Kondo H, et al. Evaluating local hepatocellular carcinoma recurrence post-transcatheter arterial chemoembolization: is diffusion-weighted MRI reliable as an indicator? J Magn Reson Imaging 2008;27:834-839.
17. Earls JP, Rofsky NM, DeCorato DR, et al. Hepatic arterial-phase dynamic gadolinium-enhanced MR imaging: optimization with a test examination and a power injector. Radiology 1997;202:268-273. (Pubitemid 27024138)
18. Yu JS. Hepatocellular carcinoma after transcatheter arterial chemoembolization: difficulties on imaging follow-up. Korean J Radiol 2005;6:134-135. (Pubitemid 41296871)
19. Hwang SH, Yu JS, Chung J, Chung JJ, Kim JH, Kim KW. Transient hepatic attenuation difference (THAD) following transcatheter arterial chemoembolization for hepatic malignancy: changes on serial CT examinations. Eur Radiol 2008;18:1596-1603.
20. Imaging of malignant focal liver lesions. In: Schneider G, Grazioli L, Saini S, editors. MRI of the liver. 2nd edition. Milan: Springer; 2006. p 187-236.
21. Namimoto T, Yamashita Y, Sumi S, Tang Y, Takahashi M. Focal liver masses: characterization with diffusion-weighted echo-planar MR imaging. Radiology 1997;204:739-744. (Pubitemid 27369034)
22. Kim T, Murakami T, Takahashi S, Hori M, Tsuda K, Nakamura H. Diffusion-weighted single-shot echoplanar MR imaging for liver disease. AJR Am J Roentgenol 1999;173:393-398. (Pubitemid 29347365)
23. Yamada I, Aung W, Himeno Y, Nakagawa T, Shibuya H. Diffusion coefficients in abdominal organs and hepatic lesions: evaluation with intravoxel incoherent motion echo-planar MR imaging. Radiology 1999;210:617-623. (Pubitemid 29124018)
24. Taouli B, Vilgrain V, Dumont E, Daire JL, Fan B, Menu Y. Evaluation of liver diffusion isotrophy and characterization of focal hepatic lesions with two single-shot echo-planar MR imaging sequences: prospective study in 66 patients. Radiology 2003;226:71-78. (Pubitemid 36163910)
25. Lee JD, Lee JM, Kim SW, Kim CS, Mun WS. MR imaging-histopathologic correlation of radiofrequency thermal ablation lesion in a rabbit liver model: observation during acute and chronic stages. Korean J Radiol 2001;2:151-158. (Pubitemid 33687587)
26. Itoh Y, Okanoue T, Ohnishi N, et al. Hepatic damage induced by transcatheter arterial chemoembolization elevates serum concentrations of macrophage-colony stimulating factor. Liver 1999;19:97-103. (Pubitemid 29139761)
27. Shinya S, Sasaki T, Nakagawa Y, Guiquing Z, Yamamoto F, Yamashita Y. Acute pancreatitis successfully diagnosed by diffusion- weighted imaging: a case report. World J Gastroenterol 2008;14:5478-5480.
28. Taouli B, Tolia AJ, Losada M, et al. Diffusion-weighted MRI for quantification of liver fibrosis: preliminary experience. AJR Am J Roentgenol 2007;189:799-806. (Pubitemid 47479760)
29. Kamel IR, Bluemke DA, Ramsey D, et al. Role of diffusion-weighted imaging in estimating tumor necrosis after chemoembolization of hepatocellular carcinoma. AJR Am J Roentgenol 2003;181:708-710. (Pubitemid 37021839)
30. Naganawa S, Kawai H, Fukatsu H, et al. Diffusion-weighted imaging of the liver: technical challenges and prospects for the future. Magn Reson Med Sci 2005;4:175-186.